Literature DB >> 19317956

Tolerability of antipsychotics: recent controversies and future management.

W Wolfgang Fleischhacker1.   

Abstract

Individuals with schizophrenia experience increased morbidity and mortality due to both natural and unnatural causes. Some antipsychotics used to treat this disorder may contribute to the poor physical health in this population. Clinicians must accept responsibility for both the physical and mental health care of patients with schizophrenia by preferentially selecting antipsychotics with a low incidence of adverse side effects, monitoring for any metabolic disturbances that may be associated with these drugs, and actively managing risk factors that may worsen patients' physical health. ©Copyright 2009 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19317956     DOI: 10.4088/JCP.7062br1c.e06

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

1.  The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.

Authors:  Maria Ferrara; Anya Umlauf; Chelsea Sanders; Jonathan M Meyer; John Allen McCutchan; Nichole Duarte; Joseph Hampton Atkinson; Igor Grant; Ronald J Ellis
Journal:  Psychiatry Res       Date:  2014-04-18       Impact factor: 3.222

2.  SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects.

Authors:  Peter M Haddad; W Wolfgang Fleischhacker; Joseph Peuskens; Roberto Cavallaro; Michael Ej Lean; Margarita Morozova; Gavin Reynolds; Jean-Michel Azorin; Pierre Thomas; Hans-Jürgen Möller
Journal:  Ther Adv Psychopharmacol       Date:  2014-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.